pyrazolanthrone has been researched along with Hyperglycemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacca, A; Koulajian, K; Tai, K; Tang, C; Volchuk, A; Yeung, LSN; Zhang, L | 1 |
| Chen, J; Guo, R; Huang, R; Li, S; Tian, L; Wu, K; Yan, H; You, Q | 1 |
| Kim, CE; Kim, MH; Kim, SW | 1 |
| Reece, EA; Yang, P; Zhao, Z | 2 |
5 other study(ies) available for pyrazolanthrone and Hyperglycemia
| Article | Year |
|---|---|
Glucose-Induced β-Cell Dysfunction In Vivo: Evidence for a Causal Role of C-jun N-terminal Kinase Pathway.
Topics: Animals; Anthracenes; Diabetes Mellitus, Type 2; Glucose; Glucose Clamp Technique; Homeodomain Proteins; Hyperglycemia; In Vitro Techniques; Insulin; Insulin-Secreting Cells; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 8; Protein Kinase Inhibitors; Rats; RNA, Messenger; Signal Transduction; Trans-Activators | 2018 |
Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Butadienes; Cell Line; Cell Survival; Enzyme Inhibitors; Flavanones; Fruit; Glucose; Hyperglycemia; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Pyridines; Rats; Reactive Oxygen Species | 2014 |
Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells.
Topics: Anthracenes; Butadienes; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Flavanones; Glucose; Hesperidin; Humans; Hyperglycemia; Imidazoles; Intercellular Adhesion Molecule-1; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Resveratrol; Stilbenes; Up-Regulation; Veins | 2011 |
Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy.
Topics: Animals; Anthracenes; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Activation; Female; Genotype; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 9; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Culture Techniques | 2007 |
Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro.
Topics: Animals; Anthracenes; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Vascular Diseases; Yolk Sac | 2008 |